Plasma Biomarkers Ascertained With Immunomagnetic Reduction Diagnosing Early-Stage Alzheimer's Disease: A Systematic Review
Introduction: Alzheimer's disease (AD) will become a prominent public health issue in the future given its cognitively debilitating nature. As the advent of global ageing society is expected, AD may bring tremendous socioeconomical costs if current diagnosis methods stay put. In this article, w...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Innovative Healthcare Institute
2021-01-01
|
| Series: | Innovations in Digital Health, Diagnostics, and Biomarkers |
| Subjects: | |
| Online Access: | https://theijpt.org/doi/pdf/10.36401/IDDB-20-04 |